Clinical trial
Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
NCT00131664 · Canadian Heart Research Centre, Other · Completed
Key facts
| NCT number | NCT00131664 |
|---|---|
| Title | Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) |
| Official title | Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin: A 48-week Randomized, Open-label, Multicentre Phase IIIB Study to Compare the Effectiveness of Combination Therapy to Monotherapy in Type 2 Diabetes Mellitus Patients |
| Acronym | AVALANCHE |
| Lead sponsor | Canadian Heart Research Centre, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Avandamet, Avandia and Amaryl, Metformin |
| Enrollment | 391 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Aug 19, 2005 |
| Last update posted | Apr 17, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: